Mike Matson
Stock Analyst at Needham
(3.47)
# 921
Out of 5,090 analysts
532
Total ratings
47.7%
Success rate
4.61%
Average return
Main Sectors:
Stocks Rated by Mike Matson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Reiterates: Buy | $448 | $364.02 | +23.07% | 10 | Nov 14, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $3 | $1.03 | +191.26% | 22 | Nov 13, 2025 | |
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $4.25 → $9 | $5.24 | +71.76% | 2 | Nov 11, 2025 | |
| HAE Haemonetics | Maintains: Buy | $68 → $78 | $83.94 | -7.08% | 15 | Nov 7, 2025 | |
| AORT Artivion | Maintains: Buy | $50 → $58 | $44.59 | +30.07% | 20 | Nov 7, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $48 → $70 | $70.79 | -1.12% | 4 | Nov 6, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $10 | $9.56 | +4.60% | 21 | Nov 5, 2025 | |
| VCYT Veracyte | Maintains: Buy | $41 → $44 | $44.61 | -1.37% | 18 | Nov 5, 2025 | |
| MMSI Merit Medical Systems | Reiterates: Buy | $108 | $83.43 | +29.45% | 31 | Oct 31, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $42 → $26 | $18.42 | +41.15% | 24 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $326 | $300.66 | +8.43% | 12 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $148 | $136.51 | +8.42% | 13 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $74.97 | - | 22 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $121 | $97.52 | +24.08% | 34 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $14.42 | - | 21 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $64 | $63.36 | +1.01% | 27 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $14 | $11.90 | +17.65% | 27 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $101.36 | - | 21 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $49 | $27.02 | +81.35% | 16 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $45 | $39.86 | +12.90% | 35 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $61 | $40.07 | +52.23% | 25 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $6.94 | +72.91% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $141.68 | - | 25 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $142.51 | - | 5 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $263.28 | - | 11 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $120.50 | - | 9 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $94.28 | - | 26 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $256.55 | - | 14 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $19.68 | +113.41% | 2 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $75 | $91.10 | -17.67% | 1 | Feb 18, 2021 |
Stryker
Nov 14, 2025
Reiterates: Buy
Price Target: $448
Current: $364.02
Upside: +23.07%
Lucid Diagnostics
Nov 13, 2025
Reiterates: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
Insight Molecular Diagnostics
Nov 11, 2025
Maintains: Buy
Price Target: $4.25 → $9
Current: $5.24
Upside: +71.76%
Haemonetics
Nov 7, 2025
Maintains: Buy
Price Target: $68 → $78
Current: $83.94
Upside: -7.08%
Artivion
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $58
Current: $44.59
Upside: +30.07%
Establishment Labs Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $48 → $70
Current: $70.79
Upside: -1.12%
Personalis
Nov 5, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $9.56
Upside: +4.60%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $41 → $44
Current: $44.61
Upside: -1.37%
Merit Medical Systems
Oct 31, 2025
Reiterates: Buy
Price Target: $108
Current: $83.43
Upside: +29.45%
OrthoPediatrics
Oct 29, 2025
Maintains: Buy
Price Target: $42 → $26
Current: $18.42
Upside: +41.15%
Oct 27, 2025
Reiterates: Buy
Price Target: $326
Current: $300.66
Upside: +8.43%
Oct 23, 2025
Upgrades: Buy
Price Target: $148
Current: $136.51
Upside: +8.42%
Oct 21, 2025
Reiterates: Hold
Price Target: n/a
Current: $74.97
Upside: -
Oct 17, 2025
Reiterates: Buy
Price Target: $121
Current: $97.52
Upside: +24.08%
Oct 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $14.42
Upside: -
Sep 3, 2025
Reiterates: Buy
Price Target: $64
Current: $63.36
Upside: +1.01%
Aug 29, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $11.90
Upside: +17.65%
Aug 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $101.36
Upside: -
Aug 7, 2025
Maintains: Buy
Price Target: $57 → $49
Current: $27.02
Upside: +81.35%
Jul 30, 2025
Maintains: Buy
Price Target: $44 → $45
Current: $39.86
Upside: +12.90%
Jun 12, 2025
Downgrades: Hold
Price Target: $61
Current: $40.07
Upside: +52.23%
May 22, 2025
Upgrades: Buy
Price Target: $12
Current: $6.94
Upside: +72.91%
Apr 10, 2025
Reiterates: Hold
Price Target: n/a
Current: $141.68
Upside: -
Apr 8, 2025
Reiterates: Hold
Price Target: n/a
Current: $142.51
Upside: -
Apr 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $263.28
Upside: -
Mar 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $120.50
Upside: -
Feb 7, 2025
Reiterates: Hold
Price Target: n/a
Current: $94.28
Upside: -
Jan 31, 2025
Reiterates: Hold
Price Target: n/a
Current: $256.55
Upside: -
May 4, 2021
Maintains: Buy
Price Target: $34 → $42
Current: $19.68
Upside: +113.41%
Feb 18, 2021
Maintains: Buy
Price Target: $65 → $75
Current: $91.10
Upside: -17.67%